Xenon Pharmaceuticals Inc. Business Operations Contracts & Agreements

10 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement, dated March 1, 2022, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company,...
Sales Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2022
Amendment #2, dated February 25, 2022, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc
Collaboration Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2022
Termination Agreement, dated August 6, 2021, by and among Xenon Pharmaceuticals Inc., Genentech, Inc. and F. Hoffmann-La Roche Ltd
Termination Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2021
Amendment #1, dated January 13, 2021, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc
Collaboration Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2021
At-the-Market Equity Offering Sales Agreement dated as of August 6, 2020, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2020
At-the-Market Equity Offering Sales Agreement dated as of November 5, 2019, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2019
At-the-Market Equity Offering Sales Agreement, dated as of July 11, 2018, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2018
At-the-Market Equity Offering Sales Agreement, dated as of May 8, 2018, between Xenon Pharmaceuticals Inc. and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2018
Termination Agreement by and among Xenon Pharmaceuticals Inc., Teva Pharmaceuticals International GmbH and Teva Canada Limited dated March 7, 2018
Termination Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2018
INDEMNIFICATION AGREEMENT BETWEEN XENONPHARMACEUTICALS INC. AND MADE AS OF , 2014 INDEMNIFICATION AGREEMENT,
Indemnification Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2014